Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares are trading lower by $12.00 (2.2 percent) at $464.84 in Thursday's session. The decline may be a delayed reaction to the company's 8-K filing released before Wednesday's open.
Also on Wednesday, Pfizer (NYSE:PFE) and Eli Lilly (NYSE:LLY) received fast track designation to their pipeline candidate, Tanezumab, for the treatment of chronic pain in patients with osteoarthritis This drug candidate is in direct completion for a similar drug being developed by Regeneron.
After a lower open, Regeneron's stock couldn't regain Wednesday's close ($476.84), only reaching $475.80 before continuing its move lower. So far, the ensuing decline took the stock to $461.58, but rebounded back into the mid-$460.00 handle. That marks its lowest level since it bottomed on June 1 at $459.53.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!